Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Docetaxel in Patients With Inflammatory or Locally Advanced Breast Cancer. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Avastin in combination with capecitabine and docetaxel for inflammatory or locally advanced breast cancer has been terminated; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Taxotere (docetaxel)
• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-08-11